News
EPS beats expectations, revenue lags
Ypsomed Holding (VTX:YPSN) Complete results for the year 2024
Main financial results
-
Revenue: CHF 548.5 million (10% increase compared to fiscal year 2023).
-
Net profit: CHF 78.4 million (53% increase compared to fiscal year 2023).
-
Profit margin: 14% (up from 10% in FY2023). The margin increase was driven by increased revenue.
-
EPS: CHF 5.74 (up from CHF 3.82 in FY 2023).
earnings and income history
All numbers shown in the chart above are for the period of the last 12 months (TTM)
Ypsomed Holding EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) beat analyst estimates by 3.2%.
Looking ahead, revenue is forecast to grow by an average of 16% per year over the next 3 years, compared to a 7.6% growth forecast for the Medical Equipment industry in Switzerland.
Performance of Swiss medical equipment industry.
The company’s shares rose 15% from the previous week.
Risk analysis
Be aware that Ypsomed Holding is exhibiting 1 warning sign in our investment analysis that you should know…
Do you have feedback on this article? Worried about the content? Get in touch with us directly. Alternatively, email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts using only an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take into account your objectives or your financial situation. Our goal is to bring you long-term focused analysis driven by fundamental data. Please note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St has no position in any of the stocks mentioned.